BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 1341608)

  • 1. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
    Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microalbuminuria in insulin-dependent diabetics: the prevention of diabetic nephropathy].
    Durruty P; Krause P; Pérez F; García de los Ríos M; López G; Durruty G
    Rev Med Chil; 1990 Dec; 118(12):1319-25. PubMed ID: 2152662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study.
    Sano T; Hotta N; Kawamura T; Matsumae H; Chaya S; Sasaki H; Nakayama M; Hara T; Matsuo S; Sakamoto N
    Diabet Med; 1996 Feb; 13(2):120-4. PubMed ID: 8641115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
    Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
    Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enalapril in patients with diabetes mellitus type I with microalbuminuria without hypertension].
    Semetkowska-Jurkiewicz E; Milewski J; Krupa-Wojciechowska B; Wójcikowski C; Horoszek-Maziarz S
    Pol Tyg Lek; 1993 Jan 4-11; 48(1-2):19-21, 26. PubMed ID: 8361875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of enalapril on microalbuminuria and lipid profile of normotensive type I diabetes mellitus patients].
    Hernández Mijares A; Barberá Comes G; Lluch Verdú I; Morillas Ariño C; Real Collado J; Lorente Calvo R; González Bayo E; Carmena Rodríguez R
    Rev Clin Esp; 1996 Jun; 196(6):354-8. PubMed ID: 8767069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
    Lebovitz HE; Wiegmann TB; Cnaan A; Shahinfar S; Sica DA; Broadstone V; Schwartz SL; Mengel MC; Segal R; Versaggi JA
    Kidney Int Suppl; 1994 Feb; 45():S150-5. PubMed ID: 8158885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA; Cowan P; Patrick AW; Clarke BF
    Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.